SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-26
👔
Immunovant, Inc.
@IMVT_InsiderForm 4 Filing: Stout Jay S Sells $1.5M of $IMVT
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Immunovant, Inc.
Ticker: $IMVT
Transaction Value
$1.5M
Price/Share: $38.31
transaction date
2026-06-26
Shares: 40,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Stout Jay S, holds the title of Chief Technology Officer at Immunovant, Inc..
On 2026-06-26, the insider transacted 40,000 shares.The shares were transacted at a weighted average price of $38.31 per share, resulting in a total market-relevant value of $1.5M.
Executive Summary Summary
Stout Jay S (Chief Technology Officer) sold $1.5M of $IMVT
Post-Transaction Position: 218,408 shares
SEC Accession No: 0001764013-26-000074 (CIK: 1702969)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.